The Centers for Medicare and Medicaid Services (CMS) identified 15 drugs it has selected for price negotiations with drug ...
Robert F. Kennedy Jr., who's nominated to become the next health secretary, asked the federal government to revoke its ...
A federal judge in Texas is allowing three other states to pursue a challenge seeking to restrict access to the abortion pill ...
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
Trump-appointed Judge Matthew Kacsmaryk ruled Thursday that Idaho, Kansas, and Missouri can pursue legal action to prohibit ...
AND EARLIER THIS WEEK, THE FDA ANNOUNCED THE BAN OF RED DYE NUMBER THREE. THE CONTROVERSIAL INGREDIENT OFTEN FOUND IN DRINKS, CANDY AND CEREAL. I’M JOINED NOW BY DOCTOR TARA KESTER, AND INTEGRATED ...
Temple pulmonologist Dr. Jamie Garfield says the proposed regulation is an effective harm reduction strategy, but suggests it ...
Following the ban of red dye No. 3 in the United States, experts weigh in on the potential health risks of red dye No. 40, ...
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...
Robert F. Kennedy Jr. petitioned the F.D.A. to revoke authorization of the shots at a time when they were in high demand and ...
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.